Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$0.4 - $0.63 $4 - $7
-12 Reduced 12.0%
88 $0
Q2 2023

Aug 11, 2023

SELL
$0.51 - $0.67 $7 - $10
-15 Reduced 13.04%
100 $0
Q1 2023

May 15, 2023

BUY
$0.6 - $0.91 $57 - $86
95 Added 475.0%
115 $0
Q4 2022

Feb 13, 2023

SELL
$0.48 - $5.33 $0 - $10
-2 Reduced 9.09%
20 $0
Q3 2022

Nov 14, 2022

SELL
$4.65 - $7.37 $18 - $29
-4 Reduced 15.38%
22 $0
Q2 2022

Aug 10, 2022

BUY
$4.21 - $11.15 $12 - $33
3 Added 13.04%
26 $0
Q1 2022

May 13, 2022

SELL
$8.48 - $18.1 $50 - $108
-6 Reduced 20.69%
23 $0
Q4 2021

Feb 10, 2022

BUY
$15.37 - $22.5 $445 - $652
29 New
29 $0

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.82B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.